
Please try another search
Glycorex Transplantation AB (publ), a medical technology company, focuses on transplantation, blood transfusion, and autoimmune diseases. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company’s principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures. It serves in Europe, Austria, Germany, the Netherlands, the United Kingdom, Canada, and Spain. Glycorex Transplantation AB (publ) was incorporated in 1995 and is headquartered in Lund, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Kurt Nilsson | 71 | 1996 | Chairman of the Board |
Tomas Westergren | 60 | 2012 | Deputy Director |
Fredrik Johansson | 36 | 2023 | Director |
Roland Frosing | 64 | 2024 | Director |
Joakim Jagorstrand | 55 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review